Robichaud Albert 4
4 · Sage Therapeutics, Inc. · Filed Apr 30, 2020
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-28+9,450→ 9,450 totalExercise: $39.87Exp: 2030-04-28→ Common Stock (9,450 underlying)
Footnotes (1)
- [F1]The securities awarded on April 28, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. 25% of the shares of common stock underlying this stock option award will vest on April 28, 2021, and the remaining 75% of the shares of common stock underlying this stock option award will vest on April 28, 2022, subject, in each case, to the Reporting Person's continued employment with the Issuer on each of the applicable vesting dates.